Back to 
Centiva Capital, LP
Centiva Capital, LP
GOSS
Showing 0 of 2 quarters
Position history for Centiva Capital, LP's holdings in GOSSAMER BIO INC
No. Centiva Capital exited its GOSS (Gossamer Bio) position in Q2 2023. Its Q1 2023 13F listed 265,920 shares worth $335,059. Centiva Capital first reported GOSS in Q1 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.